Colorectal Liver Metastases Clinical Trial
Official title:
Preoperative Hepatic Arterial Infusion Chemotherapy in Patients Undergoing Liver Resection for Colorectal Liver Metastases
To assess the feasibility and results of liver resection after preoperative hepatic artery infusion (HAI) chemotherapy with FUDR.
Between 1995 and 2004, 239 patients with isolated colorectal liver metastases received HAI
chemotherapy with neoadjuvant intent. Fifty of these patients underwent subsequent curative
liver resection (HAI group).
Postoperative morbidity, liver function tests, and long term outcomes were evaluated.
Adverse events related to HAI chemotherapy were also evaluated.
;
Observational Model: Defined Population, Time Perspective: Longitudinal
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT01255007 -
Comparison of Primovist-enhanced MRI, Diffusion Weighted MRI and Multidetector CT of Colorectal Liver Metastases
|
N/A | |
Completed |
NCT00779272 -
Impact of Preoperative Chemotherapy on Complications and Regeneration After Resection of Colorectal Liver Metastases
|
N/A | |
Active, not recruiting |
NCT00797251 -
Anatomical Right Posterior Sectionectomy of the Liver by IOUS-Guided Finger Compression
|
N/A | |
Recruiting |
NCT06045286 -
High- and Low-dose Radiotherapy Combined With PD-1 Inhibitors for MSS CRLM
|
Phase 1 | |
Recruiting |
NCT04870879 -
Colorectal Metastasis and Liver Transplantation With Organs From Deceased Donors
|
N/A | |
Completed |
NCT01799044 -
Pilot-study: Non-thermal Ablation Using Irreversible Electroporation to Treat Colorectal Liver Metastases
|
Phase 1 | |
Terminated |
NCT00508872 -
Folfox-B Study for Patients With Colorectal Liver Metastases
|
Phase 2 | |
Recruiting |
NCT05877001 -
The Safety and Efficacy of HAIC+Tislelizumab+Regorafenib in Patients With Colorectal Liver Metastases
|
Phase 2 | |
Completed |
NCT02082782 -
Efficacy of Irreversible Electroporation (IRE) for Central Colorectal Liver Metastases
|
Phase 2 | |
Completed |
NCT00942292 -
The Effect of Fish Oils on Human Hepatic Colorectal Metastases
|
Phase 2 | |
Recruiting |
NCT01191632 -
Effect of Neoadjuvant Radiation on Tumor Infiltrating T-cells by Low Dose Radiation in Colorectal Liver Metastases
|
Phase 1/Phase 2 | |
Completed |
NCT00119899 -
Utility of FDG-PET Scan on the Selection of Patients for Resection of Hepatic Colorectal Metastases
|
Phase 3 | |
Completed |
NCT00184834 -
Quality of Life and Liver Metastases
|
N/A | |
Completed |
NCT00557557 -
Safety Study of Oxaliplatin and 5-fluorouracil Followed by FUDR for Unresectable Colorectal Liver Metastases
|
Phase 1 | |
Recruiting |
NCT05468593 -
Patient Outcomes After Hepatic Artery Infusion Pump Placement
|
||
Completed |
NCT02615665 -
Intratumoral CD3+ and NKp46+ Cells in Colorectal Liver Metastases
|
N/A | |
Terminated |
NCT01318447 -
CyberKnife® for Hepatic Metastases From Colorectal Cancer
|
Phase 2 | |
Completed |
NCT00885950 -
Prevention of the Hepatic Sinusoidal Obstruction Syndrome by Means of Anticoagulants
|
N/A | |
Completed |
NCT02331641 -
Multiple Minor Hepatectomies Versus Major or Extended Hepatectomies for Colorectal Liver Metastases.
|
N/A | |
Completed |
NCT00600522 -
Alternative Surgical Policy for Central Liver Tumors
|
N/A |